CordenPharma in France Reports Successful FDA Inspection
Article
PTSM: Pharmaceutical Technology Sourcing and Management
PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
Volume 11
Issue 9
The CordenPharma Chenôve, France manufacturing facility completed an FDA Inspection with no 483s reported.
CordenPharma announced on Aug. 31, 2016 that the CordenPharma Chenôve (France) manufacturing facility completed an FDA Inspection and received a successful response with no 483s reported. The previous FDA Inspection took place in 2014.
Yves Michon, Managing Director of CordenPharma Chenôve comments, “We are pleased with the outcome of the FDA Inspection in August 2016, as it reflects our willingness to comply with the highest level of cGMP regulatory compliance while continuously improving our standards for our customers and their projects going forward.”
Source: CordenPharma
Articles in this issue
Putting Shelf-Life to the Test
The Enzymatic Catalysis Route to Going Green
CMOs Step Up to Test New Bioprocessing Technology
SGS Opens New Facility in Wiesbaden, Germany
CSafe Acquires Kallibox
CordenPharma in France Reports Successful FDA Inspection
Automated Infrared Microscope Effectively Analyzes Micro Samples
Copley Scientific Launches Products for Tablet Dissolution Testing
Eppendorf Expands Single-Use Vessel Portfolio
PANalytical launches the Empyrean Nano edition
Fuji Health Changes Name to Fuji Chemical Industries USA, Inc.
Regis Technologies Reports Successful FDA Inspection
Evonik Birmingham Laboratories Receives Renewal of EU GMP Certification
Quality Issues Cited at Frontida BioPharm
Recipharm Expands Lyophilization Capacity in Italy
Recent Videos
